Moreover, we tried to determine whether the mutants of GIT1 (GIT1Mut1: GIT1L271A; GIT1Mut2: GIT1L279A) influenced the drug-induced inhibition of gastric cancer cell invasion and Rac1 activation. This evidence concerns the gene RAC1 and gastric cancer.